Abstract |
The antitumor efficiency of dendritic cells transduced with an adenovirus vector expressing secondary lymphoid chemokine (CCL21) was evaluated in a murine model of spontaneous bronchoalveolar cell carcinoma. The transgenic mice (CC-10 TAg) express the SV40 large T antigen (TAg) under the Clara cell promoter, develop bilateral, multifocal, and pulmonary adenocarcinomas, and die at 4 months as a result of progressive pulmonary tumor burden. A single intratracheal administration of CCL21 gene-modified dendritic cells (DC-AdCCL21) led to a marked reduction in tumor burden with extensive mononuclear cell infiltration of the tumors. The reduction in tumor burden was accompanied by the enhanced elaboration of type 1 cytokines [IFN-gamma, interleukin (IL)-12, and granulocyte macrophage colony-stimulating factor] and antiangiogenic chemokines (CXCL9 and CXCL10) but a concomitant decrease in the immunosuppressive molecules (IL-10, transforming growth factor-beta, prostaglandin E(2)) in the tumor microenvironment. The DC-AdCCL21 therapy group revealed a significantly greater frequency of tumor-specific T cells releasing IFN-gamma compared with the controls. Continuous therapy with weekly intranasal delivery of DC-AdCCL21 significantly prolonged median survival by >7 weeks in CC-10 TAg mice. Both innate natural killer and specific T-cell antitumor responses significantly increased following DC-AdCCL21 therapy. Significant reduction in tumor burden in a model in which tumors develop in an organ-specific manner provides a strong rationale for further evaluation of intrapulmonary-administered DC-AdCCL21 in regulation of tumor immunity and genetic immunotherapy for lung cancer.
|
Authors | Seok-Chul Yang, Raj K Batra, Sven Hillinger, Karen L Reckamp, Robert M Strieter, Steven M Dubinett, Sherven Sharma |
Journal | Cancer research
(Cancer Res)
Vol. 66
Issue 6
Pg. 3205-13
(Mar 15 2006)
ISSN: 0008-5472 [Print] United States |
PMID | 16540672
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- Antigens, Viral, Tumor
- Ccl21c protein, mouse
- Chemokine CCL21
- Chemokines, CC
- Cytokines
|
Topics |
- Adenocarcinoma, Bronchiolo-Alveolar
(genetics, immunology, therapy)
- Animals
- Antigens, Viral, Tumor
(immunology)
- Chemokine CCL21
- Chemokines, CC
(genetics, immunology)
- Cytokines
(immunology, metabolism)
- Dendritic Cells
(immunology, physiology)
- Genetic Therapy
(methods)
- Immunotherapy, Adoptive
(methods)
- Lung Neoplasms
(genetics, immunology, therapy)
- Mice
- Mice, Transgenic
- T-Lymphocytes
(immunology)
|